149822583	149822583	CD	B-NP	O
|	|	NN	I-NP	O
LAH	LAH	NN	I-NP	O
|	|	NN	I-NP	O
32272904	32272904	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
820254	820254	CD	B-NP	O
|	|	CC	I-NP	O
7/14/1995	7/14/1995	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Summary	Summary	NNP	I-NP	O
|	|	NNP	I-NP	O
Signed	Signed	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/5/1995	10/5/1995	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
3/2/1995	3/2/1995	CD	B-NP	O
PRIMARY	PRIMARY	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
PNEUMONIA	PNEUMONIA	NNP	B-NP	O
,	,	,	O	O
LEFT	LEFT	NNP	B-NP	O
UPPER	UPPER	NNP	I-NP	O
LOBE	LOBE	NNP	I-NP	O
.	.	.	O	O

OTHER	OTHER	NN	B-NP	O
DIAGNOSES	DIAGNOSES	NNS	I-NP	O
:	:	:	O	O
URINARY	URINARY	NN	B-NP	O
TRACT	TRACT	NN	I-NP	O
INFECTION	INFECTION	NN	I-NP	O
.	.	.	O	O

URINARY	URINARY	NN	B-NP	O
INCONTINENCE	INCONTINENCE	NN	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
Mr.	Mr.	NNP	B-NP	O
Nittinger	Nittinger	NNP	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
70-year-old	70-year-old	JJ	I-NP	O
male	male	NN	I-NP	O
with	with	IN	B-PP	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
non-insulin-dependent	non-insulin-dependent	JJ	B-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
75-pack-year	75-pack-year	JJ	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
tobacco	tobacco	NN	B-NP	O
use	use	NN	I-NP	O
,	,	,	O	O
who	who	WP	B-NP	O
presented	present	VBD	B-VP	O
on	on	IN	B-PP	O
7/20	7/20	CD	B-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
Los	Los	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
four-day	four-day	JJ	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
subjective	subjective	JJ	B-NP	O
fever	fever	NN	I-NP	O
and	and	CC	O	O
nonproductive	nonproductive	JJ	B-NP	O
cough	cough	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
denied	deny	VBD	B-VP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
orthopnea	orthopnea	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
paroxysmal	paroxysmal	JJ	B-NP	O
nocturnal	nocturnal	JJ	I-NP	O
dyspnea	dyspnea	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
reported	report	VBD	B-VP	O
perfuse	perfuse	NN	B-NP	O
sweating	sweating	NN	I-NP	O
,	,	,	O	O
usually	usually	RB	B-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
fever	fever	NN	B-NP	O
,	,	,	O	O
but	but	CC	O	O
denied	deny	VBD	B-VP	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
exposure	exposure	NN	B-NP	O
to	to	TO	B-PP	O
tuberculosis	tuberculosis	NN	B-NP	O
or	or	CC	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
tuberculosis	tuberculosis	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
denied	deny	VBD	B-VP	O
sick	sick	JJ	B-NP	O
contacts	contact	NNS	I-NP	O
and	and	CC	O	O
reported	report	VBD	B-VP	O
having	have	VBG	I-VP	O
had	have	VBD	I-VP	O
an	an	DT	B-NP	O
influenza	influenza	NN	I-NP	O
vaccine	vaccine	NN	I-NP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
past	past	JJ	I-NP	O
winter	winter	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
having	have	VBG	B-VP	O
a	a	DT	B-NP	O
Pneumovax	Pneumovax	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
also	also	RB	B-ADVP	O
reported	report	VBD	B-VP	O
feeling	feeling	NN	B-NP	O
fatigued	fatigue	VBN	B-VP	O
about	about	RB	B-NP	O
one	one	CD	I-NP	O
week	week	NN	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
and	and	CC	O	O
,	,	,	O	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
night	night	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
felt	feel	VBD	B-VP	O
his	his	PRP$	B-NP	O
legs	leg	NNS	I-NP	O
collapse	collapse	NN	I-NP	O
under	under	IN	B-PP	O
him	him	PRP	B-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
weakness	weakness	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
denied	deny	VBD	B-VP	O
head	head	NN	B-NP	O
trauma	trauma	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
said	say	VBD	B-VP	O
he	he	PRP	B-NP	O
fell	fall	VBD	B-VP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
outstretched	outstretched	JJ	I-NP	O
arm	arm	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
no	no	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
seizure	seizure	NN	B-NP	O
disorder	disorder	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
fully	fully	RB	B-ADJP	O
conscious	conscious	JJ	I-ADJP	O
throughout	throughout	IN	B-PP	O
the	the	DT	B-NP	O
event	event	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
called	call	VBD	B-VP	O
his	his	PRP$	B-NP	O
daughter	daughter	NN	I-NP	O
who	who	WP	B-NP	O
brought	bring	VBD	B-VP	O
him	him	PRP	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Collti	Collti	NNP	I-NP	O
Eshard	Eshard	NNP	I-NP	O
Emergency	Emergency	NNP	I-NP	O
Room	Room	NNP	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
there	there	RB	B-ADVP	O
and	and	CC	O	O
evaluated	evaluate	VBN	B-VP	O
,	,	,	O	O
and	and	CC	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Napin	Napin	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
early	early	JJ	I-NP	O
morning	morning	NN	I-NP	O
hours	hour	NNS	I-NP	O
of	of	IN	B-PP	O
6/15/95	6/15/95	CD	B-NP	O
as	as	IN	B-SBAR	O
he	he	PRP	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
Pagham	Pagham	NNP	I-NP	O
patient	patient	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Angina	Angina	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
none	none	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	JJ	I-NP	O
several	several	JJ	I-NP	O
months	month	NNS	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

Coronary	Coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

Status	Status	NNP	B-NP	O
post	post	VBD	B-VP	O
percutaneous	percutaneous	JJ	B-NP	O
transluminal	transluminal	JJ	I-NP	O
coronary	coronary	JJ	I-NP	O
angioplasty	angioplasty	NN	I-NP	O
in	in	IN	B-PP	O
2/10	2/10	CD	B-NP	O
at	at	IN	B-PP	O
which	which	WDT	B-NP	O
time	time	NN	I-NP	O
a	a	DT	B-NP	O
99	99	CD	I-NP	O
%	%	NN	I-NP	O
occlusion	occlusion	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
proximal	proximal	JJ	I-NP	O
left	left	JJ	I-NP	O
anterior	anterior	JJ	I-NP	O
descending	descending	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
30	30	CD	B-NP	O
%	%	NN	I-NP	O
after	after	IN	B-PP	O
PTCA	PTCA	NN	B-NP	B-protein
.	.	.	O	O

Status	Status	NNP	B-NP	O
post	post	NN	I-NP	O
PTCA	PTCA	NN	I-NP	O
in	in	IN	B-PP	O
1/29	1/29	CD	B-NP	O
,	,	,	O	O
again	again	RB	B-ADVP	O
with	with	IN	B-PP	O
99	99	CD	B-NP	O
%	%	NN	I-NP	O
occlusion	occlusion	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
proximal	proximal	JJ	I-NP	O
left	left	JJ	I-NP	O
anterior	anterior	JJ	I-NP	O
descending	descending	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
30	30	CD	B-NP	O
%	%	NN	I-NP	O
after	after	IN	B-PP	O
PTCA	PTCA	NN	B-NP	B-protein
.	.	.	O	O

Status	Status	NNP	B-NP	O
post	post	NN	I-NP	O
PTCA	PTCA	NN	I-NP	O
in	in	IN	B-PP	O
2/18	2/18	CD	B-NP	O
,	,	,	O	O
again	again	RB	B-ADVP	O
with	with	IN	B-PP	O
99	99	CD	B-NP	O
%	%	NN	I-NP	O
occlusion	occlusion	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
proximal	proximal	JJ	I-NP	O
left	left	JJ	I-NP	O
anterior	anterior	JJ	I-NP	O
descending	descending	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
30	30	CD	B-NP	O
%	%	NN	I-NP	O
after	after	IN	B-PP	O
PTCA	PTCA	NN	B-NP	B-protein
;	;	:	O	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
small	small	JJ	I-NP	O
complication	complication	NN	I-NP	O
in	in	IN	B-PP	O
which	which	WDT	B-NP	O
a	a	DT	B-NP	O
focal	focal	JJ	I-NP	O
dissection	dissection	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
proximal	proximal	JJ	I-NP	O
left	left	JJ	I-NP	O
anterior	anterior	JJ	I-NP	O
descending	descending	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
.	.	.	O	O
.	.	.	O	O

PAST	PAST	NN	B-NP	O
SURGICAL	SURGICAL	NN	I-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Angioplasty	Angioplasty	NNP	B-NP	O
as	as	IN	B-PP	O
above	above	RB	B-ADVP	O
.	.	.	O	O

ADMISSION	ADMISSION	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Sublingual	Sublingual	JJ	B-NP	O
Nitroglycerin	Nitroglycerin	NN	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
Lopressor	Lopressor	NN	I-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
.	.	.	O	O

p.o.	p.o.	LS	B-LST	O
b.i.d.	b.i.d.	:	O	O
Cardizem-SR	Cardizem-SR	JJ	B-NP	O
120	120	CD	I-NP	O
mg	mg	NN	I-NP	O
.	.	.	O	O

b.i.d.	b.i.d.	LS	B-NP	O
Coumadin	Coumadin	NN	I-NP	O
2.5	2.5	CD	I-NP	O
mg	mg	NN	I-NP	O
.	.	.	O	O

alternating	alternate	VBG	B-VP	O
with	with	IN	B-PP	O
3	3	CD	B-NP	O
mg	mg	NN	I-NP	O
.	.	.	O	O

p.o.	p.o.	LS	B-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

Lovastatin	Lovastatin	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
.	.	.	O	O

q.	q.	LS	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

Glyburide	Glyburide	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
.	.	.	O	O

q.	q.	LS	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
known	know	VBN	I-NP	O
drug	drug	NN	I-NP	O
allergies	allergy	NNS	I-NP	O
.	.	.	O	O

FAMILY	FAMILY	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Negative	Negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
father	father	NN	I-NP	O
had	have	VBD	B-VP	O
lung	lung	NN	B-NP	O
cancer	cancer	NN	I-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
He	He	PRP	B-NP	O
is	be	VBZ	B-VP	O
married	married	JJ	B-ADJP	O
and	and	CC	O	O
lives	live	VBZ	B-VP	O
with	with	IN	B-PP	O
wife	wife	NN	B-NP	O
and	and	CC	I-NP	O
daughter	daughter	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
75-pack-year	75-pack-year	JJ	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
tobacco	tobacco	NN	B-NP	O
use	use	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
reportedly	reportedly	RB	B-ADVP	O
was	be	VBD	B-VP	O
smoking	smoke	VBG	I-VP	O
until	until	IN	B-PP	O
two	two	CD	B-NP	O
weeks	week	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
onset	onset	NN	I-NP	O
of	of	IN	B-PP	O
illness	illness	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
denies	deny	VBZ	B-VP	O
any	any	DT	B-NP	O
use	use	NN	I-NP	O
of	of	IN	B-PP	O
alcohol	alcohol	NN	B-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
Vital	Vital	JJ	B-NP	O
signs	sign	NNS	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
Sno	Sno	NNP	I-NP	O
Valley	Valley	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
Center	Center	NNP	I-NP	O
Emergency	Emergency	NNP	I-NP	O
Room	Room	NNP	I-NP	O
revealed	reveal	VBD	B-VP	O
temperature	temperature	NN	B-NP	O
102	102	CD	I-NP	O
,	,	,	O	O
respiratory	respiratory	JJ	B-NP	O
rate	rate	NN	I-NP	O
16	16	CD	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
160/78	160/78	CD	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
the	the	DT	B-NP	O
Delf11	Delf11	NNP	I-NP	O
Valley	Valley	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
Emergency	Emergency	NNP	I-NP	O
Room	Room	NNP	I-NP	O
,	,	,	O	O
temperature	temperature	NN	B-NP	O
was	be	VBD	B-VP	O
100.7	100.7	CD	B-NP	O
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
96	96	CD	I-NP	O
,	,	,	O	O
O2	O2	NN	B-NP	O
saturations	saturation	NNS	I-NP	O
95	95	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
128/80	128/80	CD	I-NP	O
,	,	,	O	O
respiratory	respiratory	JJ	B-NP	O
rate	rate	NN	I-NP	O
20	20	CD	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
well-developed	well-developed	JJ	I-NP	O
,	,	,	I-NP	O
well-nourished	well-nourished	JJ	I-NP	O
,	,	,	I-NP	O
white	white	JJ	I-NP	O
male	male	NN	I-NP	O
who	who	WP	B-NP	O
was	be	VBD	B-VP	O
somnolent	somnolent	JJ	B-ADJP	O
but	but	CC	O	O
easily	easily	RB	B-ADJP	O
arousable	arousable	JJ	I-ADJP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
very	very	RB	B-ADJP	O
diaphoretic	diaphoretic	JJ	I-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
Emergency	Emergency	NNP	I-NP	O
Room	Room	NNP	I-NP	O
.	.	.	O	O

Neck	Neck	NN	B-NP	O
was	be	VBD	B-VP	O
supple	supple	NN	B-NP	O
with	with	IN	B-PP	O
full	full	JJ	B-NP	O
range	range	NN	I-NP	O
of	of	IN	B-PP	O
motion	motion	NN	B-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
lymphadenopathy	lymphadenopathy	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
JVP	JVP	NN	I-NP	B-protein
was	be	VBD	B-VP	O
flat	flat	JJ	B-ADJP	O
.	.	.	O	O

Lungs	Lung	NNS	B-NP	O
revealed	reveal	VBD	B-VP	O
anterior	anterior	JJ	B-NP	O
bronchial	bronchial	JJ	I-NP	O
breath	breath	NN	I-NP	O
sounds	sound	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
upper	upper	JJ	I-NP	O
lung	lung	NN	I-NP	O
field	field	NN	I-NP	O
.	.	.	O	O

Lungs	Lung	NNS	B-NP	O
were	be	VBD	B-VP	O
clear	clear	JJ	B-ADJP	O
to	to	TO	B-PP	O
auscultation	auscultation	NN	B-NP	O
posteriorly	posteriorly	RB	B-ADVP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-NP	O
exam	exam	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
a	a	DT	B-NP	O
regular	regular	JJ	I-NP	O
rate	rate	NN	I-NP	O
and	and	CC	I-NP	O
rhythm	rhythm	NN	I-NP	O
with	with	IN	B-PP	O
occasional	occasional	JJ	B-NP	O
premature	premature	JJ	I-NP	O
beats	beat	NNS	I-NP	O
.	.	.	O	O

An	An	DT	B-NP	O
S1	S1	NN	I-NP	B-protein
and	and	CC	I-NP	O
S2	S2	NN	I-NP	B-protein
were	be	VBD	B-VP	O
heard	hear	VBN	I-VP	O
.	.	.	O	O

There	There	EX	B-NP	O
were	be	VBD	B-VP	O
no	no	DT	B-NP	O
no	no	DT	I-NP	O
murmurs	murmur	NNS	I-NP	O
,	,	,	O	O
gallops	gallop	NNS	B-NP	O
,	,	,	O	O
or	or	CC	O	O
rubs	rub	NNS	B-NP	O
.	.	.	O	O

Abdomen	Abdoman	NNS	B-NP	O
was	be	VBD	B-VP	O
soft	soft	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
nontender	nontender	JJ	I-ADJP	O
.	.	.	O	O

Bowel	Bowel	NN	B-NP	O
sounds	sound	NNS	I-NP	O
were	be	VBD	B-VP	O
present	present	JJ	B-ADJP	O
.	.	.	O	O

No	No	DT	B-NP	O
masses	mass	NNS	I-NP	O
or	or	CC	I-NP	O
hepatosplenomegaly	hepatosplenomegaly	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
.	.	.	O	O

On	On	IN	B-PP	O
rectal	rectal	JJ	B-NP	O
exam	exam	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
heme-negative	heme-negative	JJ	B-NP	O
,	,	,	I-NP	O
brown	brown	JJ	I-NP	O
stool	stool	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
normal	normal	JJ	I-NP	O
tone	tone	NN	I-NP	O
;	;	:	O	O
this	this	DT	B-NP	O
was	be	VBD	B-VP	O
per	per	IN	B-PP	O
the	the	DT	B-NP	O
Emergency	Emergency	NNP	I-NP	O
Room	Room	NNP	I-NP	O
staff	staff	NN	I-NP	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
revealed	reveal	VBD	B-VP	O
no	no	DT	B-NP	O
cyanosis	cyanosis	NN	I-NP	O
,	,	,	O	O
clubbing	clubbing	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
edema	edema	NN	B-NP	O
.	.	.	O	O

Neurologic	Neurologic	JJ	B-NP	B-protein
exam	exam	NN	I-NP	I-protein
revealed	reveal	VBD	B-VP	I-protein
cranial	cranial	JJ	B-NP	I-protein
nerves	nerve	NNS	I-NP	I-protein
III	III	CD	B-NP	I-protein
through	through	IN	B-PP	O
XII	XII	NN	B-NP	B-DNA
were	be	VBD	B-VP	O
intact	intact	JJ	B-ADJP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
alert	alert	JJ	B-ADJP	O
and	and	CC	O	O
oriented	orient	VBN	B-VP	O
x	x	NN	B-NP	O
three	three	CD	I-NP	O
.	.	.	O	O

Motor	Motor	NN	B-NP	O
and	and	CC	I-NP	O
sensory	sensory	JJ	I-NP	O
exam	exam	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
5/5	5/5	CD	B-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

Reflexes	Reflex	NNS	B-NP	O
were	be	VBD	B-VP	O
0	0	CD	B-NP	O
to	to	TO	B-PP	O
1	1	CD	B-NP	O
+	+	SYM	O	O
bilaterally	bilaterally	RB	B-ADVP	O
and	and	CC	I-ADVP	O
symmetrically	symmetrically	RB	I-ADVP	O
.	.	.	O	O

Toes	Toe	NNS	B-NP	O
were	be	VBD	B-VP	O
downgoing	downgoe	VBG	I-VP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
normal	normal	JJ	B-NP	O
bulk	bulk	NN	I-NP	O
and	and	CC	I-NP	O
tone	tone	NN	I-NP	O
throughout	throughout	IN	B-ADVP	O
.	.	.	O	O

X-RAY	X-RAY	NN	B-NP	O
:	:	:	O	O
Chest	Ch	JJS	B-NP	O
x-ray	x-ray	NN	I-NP	B-DNA
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
left	left	JJ	I-NP	O
upper	upper	JJ	I-NP	O
lobe	lobe	NN	I-NP	O
infiltrate	infiltrate	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
this	this	DT	B-NP	O
was	be	VBD	B-VP	O
per	per	IN	B-PP	O
the	the	DT	B-NP	O
Ontmang	Ontmang	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
repeat	repeat	NN	I-NP	O
chest	chest	NN	I-NP	O
x-ray	x-ray	NN	I-NP	O
here	here	RB	B-ADVP	O
on	on	IN	B-PP	O
5/25/95	5/25/95	CD	B-NP	O
again	again	RB	B-ADVP	O
showed	show	VBD	B-VP	O
extensive	extensive	JJ	B-NP	O
left	left	JJ	I-NP	O
upper	upper	JJ	I-NP	O
lobe	lobe	NN	I-NP	O
pneumonia	pneumonia	NN	I-NP	O
.	.	.	O	O

ELECTROCARDIOGRAM	ELECTROCARDIOGRAM	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
electrocardiogram	electrocardiogram	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
a	a	DT	B-NP	O
normal	normal	JJ	I-NP	O
sinus	sinus	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
at	at	IN	B-PP	O
89	89	CD	B-NP	O
with	with	IN	B-PP	O
occasional	occasional	JJ	B-NP	O
premature	premature	JJ	I-NP	O
ventricular	ventricular	JJ	I-NP	O
contractions	contraction	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
Q-wave	Q-wave	JJ	I-NP	O
inversion	inversion	NN	I-NP	O
in	in	IN	B-PP	O
lead	lead	NN	B-NP	O
3	3	CD	I-NP	O
and	and	CC	I-NP	O
AVF	AVF	NN	I-NP	B-protein
,	,	,	O	O
biphasic	biphasic	JJ	B-NP	O
V3	V3	NN	I-NP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
DATA	DATA	NN	I-NP	O
:	:	:	O	O
Fluid	Fluid	NN	B-NP	O
balance	balance	NN	I-NP	O
panel	panel	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
sodium	sodium	NN	B-NP	O
131	131	NN	I-NP	O
,	,	,	O	O
potassium	potassium	NN	B-NP	O
3.4	3.4	CD	I-NP	O
,	,	,	O	O
BUN	BUN	NN	B-NP	B-protein
and	and	CC	O	O
creatinine	creatinine	NN	B-NP	O
23	23	CD	B-NP	O
and	and	CC	I-NP	O
1.4	1.4	CD	I-NP	O
,	,	,	O	O
chloride	chloride	NN	B-NP	O
and	and	CC	O	O
bicarb	bicarb	NN	B-NP	O
98	98	CD	B-NP	O
and	and	CC	I-NP	O
23	23	CD	I-NP	O
,	,	,	O	O
glucose	glucose	NN	B-NP	O
194	194	CD	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
LDH	LDH	NN	I-NP	B-protein
was	be	VBD	B-VP	O
elevated	elevate	VBN	I-VP	O
slightly	slightly	RB	B-ADVP	O
at	at	IN	B-PP	O
259	259	CD	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
other	other	JJ	I-NP	O
liver	liver	NN	I-NP	O
function	function	NN	I-NP	O
tests	test	NNS	I-NP	O
were	be	VBD	B-VP	O
within	within	IN	B-PP	O
normal	normal	JJ	B-NP	O
limits	limit	NNS	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
total	total	JJ	I-NP	O
protein	protein	NN	I-NP	O
was	be	VBD	B-VP	O
5.7	5.7	CD	B-NP	O
,	,	,	O	O
albumin	albumin	NN	B-NP	O
3.0	3.0	CD	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
hemoglobin	hemoglobin	NN	I-NP	B-protein
and	and	CC	I-NP	O
hematocrit	hematocrit	NN	I-NP	O
were	be	VBD	B-VP	O
14.4	14.4	CD	B-NP	O
and	and	CC	I-NP	O
43.3	43.3	CD	I-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
.	.	.	O	O

White	White	JJ	B-NP	O
blood	blood	NN	I-NP	O
cell	cell	NN	I-NP	O
count	count	NN	I-NP	O
was	be	VBD	B-VP	O
12	12	CD	B-NP	O
,	,	,	O	O
100	100	CD	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
differential	differential	NN	I-NP	O
of	of	IN	B-PP	O
84	84	CD	B-NP	O
%	%	NN	I-NP	O
polys	poly	NNS	I-NP	O
,	,	,	O	O
5	5	CD	B-NP	O
%	%	NN	I-NP	O
bands	band	NNS	I-NP	O
,	,	,	O	O
6	6	CD	B-NP	O
%	%	NN	I-NP	O
lymphs	lymph	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
2	2	CD	B-NP	O
%	%	NN	I-NP	O
monos	mono	NNS	I-NP	O
.	.	.	O	O

Platelet	Platelet	NN	B-NP	O
count	count	NN	I-NP	O
was	be	VBD	B-VP	O
188	188	CD	B-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
urinalysis	urinalysis	NN	I-NP	O
was	be	VBD	B-VP	O
significant	significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
white	white	JJ	B-NP	B-cell_type
blood	blood	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
and	and	CC	O	O
red	red	JJ	B-NP	B-cell_type
blood	blood	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
that	that	WDT	B-NP	O
were	be	VBD	B-VP	O
too	too	RB	B-ADJP	O
numerous	numerous	JJ	I-ADJP	O
to	to	TO	B-VP	O
count	count	VB	I-VP	O
.	.	.	O	O

He	He	PRP	B-NP	B-protein
had	have	VBD	B-VP	I-protein
3	3	CD	B-NP	I-protein
+	+	SYM	I-NP	O
bacteria	bacteria	NNS	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
PROBLEM	PROBLEM	NN	B-NP	B-protein
#	#	#	B-NP	I-protein
1	1	CD	I-NP	I-protein
:	:	:	O	O
PNEUMONIA	PNEUMONIA	NNP	B-NP	O
,	,	,	O	O
LEFT	LEFT	NNP	B-NP	O
UPPER	UPPER	NNP	I-NP	O
LOBE	LOBE	NNP	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
received	receive	VBD	B-VP	O
1	1	CD	B-NP	O
g.	g.	NN	I-NP	O
of	of	IN	B-PP	O
Cefuroxime	Cefuroxime	NN	B-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
Sontro	Sontro	NNP	I-NP	O
Cle	Cle	NNP	I-NP	O
Healthcare	Healthcare	NNP	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Termmette	Termmette	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
where	where	WRB	B-ADVP	O
Cefotaxime	Cefotaxime	NNP	B-NP	O
1	1	CD	I-NP	O
g.	g.	NN	I-NP	O
eight	eight	CD	B-NP	O
hours	hour	NNS	I-NP	O
was	be	VBD	B-VP	O
begun	begin	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
spike	spike	VB	I-VP	O
temperatures	temperature	NNS	B-NP	O
on	on	IN	B-PP	O
hospital	hospital	NN	B-NP	B-protein
days	day	NNS	I-NP	I-protein
#	#	#	B-NP	I-protein
1	1	CD	I-NP	I-protein
and	and	CC	O	I-protein
#	#	#	B-NP	I-protein
2	2	CD	I-NP	I-protein
,	,	,	O	O
although	although	IN	B-SBAR	O
blood	blood	NN	B-NP	O
and	and	CC	I-NP	O
urine	urine	NN	I-NP	B-cell_line
cultures	culture	NNS	I-NP	I-cell_line
remained	remain	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

On	On	IN	B-PP	O
hospital	hospital	NN	B-NP	O
day	day	NN	I-NP	O
#	#	#	B-NP	O
3	3	CD	I-NP	O
,	,	,	O	O
Erythromycin	Erythromycin	NN	B-NP	O
was	be	VBD	B-VP	O
added	add	VBN	I-VP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
antibiotic	antibiotic	JJ	I-NP	O
regimen	regimen	NN	I-NP	O
as	as	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
spike	spike	VB	I-VP	O
temperatures	temperature	NNS	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
following	follow	VBG	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
defervesced	defervesce	VBD	B-VP	O
and	and	CC	I-VP	O
remained	remain	VBD	I-VP	O
afebrile	afebrile	JJ	B-ADJP	O
throughout	throughout	IN	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
course	course	NN	I-NP	O
.	.	.	O	O

As	As	IN	B-SBAR	O
mentioned	mention	VBN	B-VP	O
earlier	earlier	RBR	B-ADVP	O
,	,	,	O	O
a	a	DT	B-NP	O
repeat	repeat	NN	I-NP	O
chest	chest	NN	I-NP	O
x-ray	x-ray	NN	I-NP	O
here	here	RB	B-ADVP	O
again	again	RB	B-ADVP	O
showed	show	VBD	B-VP	O
extensive	extensive	JJ	B-NP	O
left	left	JJ	I-NP	O
upper	upper	JJ	I-NP	O
lobe	lobe	NN	I-NP	O
pneumonia	pneumonia	NN	I-NP	O
.	.	.	O	O

Clinically	Clinically	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
findings	finding	NNS	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
physical	physical	JJ	I-NP	O
exam	exam	NN	I-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
resolution	resolution	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
bronchial	bronchial	JJ	I-NP	O
breath	breath	NN	I-NP	O
sounds	sound	NNS	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
lungs	lung	NNS	I-NP	O
were	be	VBD	B-VP	O
clear	clear	JJ	B-ADJP	O
to	to	TO	B-PP	O
auscultation	auscultation	NN	B-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
afebrile	afebrile	RB	B-ADVP	O
for	for	IN	B-PP	O
four	four	CD	B-NP	O
days	day	NNS	I-NP	O
and	and	CC	O	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
on	on	IN	B-PP	O
Erythromycin	Erythromycin	NN	B-NP	O
orally	orally	RB	B-ADVP	O
for	for	IN	B-PP	O
two	two	CD	B-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
intravenous	intravenous	JJ	I-NP	O
Cefotaxime	Cefotaxime	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
discontinued	discontinue	VBN	I-VP	O
two	two	CD	B-NP	O
days	day	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
at	at	IN	B-PP	O
which	which	WDT	B-NP	O
point	point	NN	I-NP	O
the	the	DT	B-NP	O
intravenous	intravenous	JJ	I-NP	O
Erythromycin	Erythromycin	NN	I-NP	O
was	be	VBD	B-VP	O
changed	change	VBN	I-VP	O
to	to	TO	B-PP	O
orally	orally	RB	B-ADVP	O
at	at	IN	B-PP	O
500	500	CD	B-NP	O
mg	mg	NN	I-NP	O
.	.	.	O	O

q.i.d.	q.i.d.	LS	B-LST	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
instructed	instruct	VBN	I-VP	O
that	that	IN	B-SBAR	O
he	he	PRP	B-NP	O
should	should	MD	B-VP	O
avoid	avoid	VB	I-VP	O
the	the	DT	B-NP	O
use	use	NN	I-NP	O
of	of	IN	B-PP	O
tobacco	tobacco	NN	B-NP	O
as	as	IN	B-SBAR	O
this	this	DT	B-NP	O
would	would	MD	B-VP	O
increase	increase	VB	I-VP	O
his	his	PRP$	B-NP	O
likelihood	likelihood	NN	I-NP	O
of	of	IN	B-PP	O
redeveloping	redevelop	VBG	B-VP	O
pneumonia	pneumonia	NN	B-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
increase	increase	VB	B-VP	O
his	his	PRP$	B-NP	O
likelihood	likelihood	NN	I-NP	O
of	of	IN	B-PP	O
worsening	worsen	VBG	B-VP	O
cardiac	cardiac	JJ	B-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
sputum	sputum	NN	I-NP	O
sample	sample	NN	I-NP	O
was	be	VBD	B-VP	O
induced	induce	VBN	I-VP	O
,	,	,	O	O
and	and	CC	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
sent	send	VBN	I-VP	O
for	for	IN	B-PP	O
routine	routine	JJ	B-NP	O
culture	culture	NN	I-NP	O
and	and	CC	I-NP	O
AFB	AFB	NN	I-NP	O
culture	culture	NN	I-NP	O
and	and	CC	I-NP	O
smear	smear	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
cultures	culture	NNS	I-NP	O
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
AFB	AFB	NN	I-NP	O
smear	smear	NN	I-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
mycobacteria	mycobacterium	NNS	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
cultures	culture	NNS	I-NP	O
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
on	on	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

PROBLEM	PROBLEM	NN	B-NP	B-protein
#	#	#	B-NP	I-protein
2	2	CD	I-NP	I-protein
:	:	:	O	O
URINARY	URINARY	NN	B-NP	O
TRACT	TRACT	NN	I-NP	O
INFECTION	INFECTION	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
Cefotaxime	Cefotaxime	NN	B-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
used	use	VBN	I-VP	O
for	for	IN	B-PP	O
treatment	treatment	NN	B-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
pneumonia	pneumonia	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
urinary	urinary	JJ	B-NP	O
incontinence	incontinence	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
by	by	IN	B-PP	O
report	report	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
incontinence	incontinence	NN	I-NP	O
had	have	VBD	B-VP	O
begun	begin	VBN	I-VP	O
approximately	approximately	RB	B-NP	O
four	four	CD	I-NP	O
or	or	CC	I-NP	O
five	five	CD	I-NP	O
days	day	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
incontinence	incontinence	NN	I-NP	O
might	might	MD	B-VP	O
be	be	VB	I-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
ongoing	ongoing	JJ	I-NP	O
infection	infection	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
repeat	repeat	NN	I-NP	O
urinalysis	urinalysis	NN	I-NP	O
was	be	VBD	B-VP	O
sent	send	VBN	I-VP	O
approximately	approximately	RB	B-NP	O
four	four	CD	I-NP	O
days	day	NNS	I-NP	O
after	after	IN	B-PP	O
admission	admission	NN	B-NP	O
and	and	CC	O	O
showed	show	VBD	B-VP	O
1	1	CD	B-NP	O
to	to	TO	B-PP	O
2	2	CD	B-NP	O
white	white	JJ	I-NP	O
blood	blood	NN	I-NP	O
cells	cell	NNS	I-NP	O
and	and	CC	O	O
0	0	CD	B-NP	O
bacteria	bacteria	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
,	,	,	O	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
point	point	NN	I-NP	O
,	,	,	O	O
no	no	RB	B-ADVP	O
longer	longer	RBR	I-ADVP	O
was	be	VBD	B-VP	O
having	have	VBG	I-VP	O
urinary	urinary	JJ	B-NP	O
incontinence	incontinence	NN	I-NP	O
;	;	:	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
large	large	JJ	I-NP	O
postvoid	postvoid	JJ	I-NP	O
residual	residual	NN	I-NP	O
of	of	IN	B-PP	O
300	300	CD	B-NP	O
cc	cc	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
might	might	MD	B-VP	O
be	be	VB	I-VP	O
related	relate	VBN	I-VP	O
in	in	IN	B-PP	O
part	part	NN	B-NP	O
to	to	TO	B-PP	O
mild	mild	JJ	B-NP	O
benign	benign	JJ	I-NP	O
prostatic	prostatic	JJ	I-NP	O
hypertrophy	hypertrophy	NN	I-NP	O
.	.	.	O	O

Dr.	Dr.	NNP	B-NP	O
Nydam	Nydam	NNP	I-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
physician	physician	NN	I-NP	O
,	,	,	O	O
is	be	VBZ	B-VP	O
aware	aware	JJ	B-ADJP	O
and	and	CC	O	O
will	will	MD	B-VP	O
pursue	pursue	VB	I-VP	O
further	further	JJ	B-NP	O
work-up	work-up	NN	I-NP	O
as	as	IN	B-PP	O
necessary	necessary	JJ	B-ADJP	O
.	.	.	O	O

PROBLEM	PROBLEM	NN	B-NP	B-protein
#	#	#	I-NP	I-protein
3	3	CD	I-NP	I-protein
:	:	:	O	O
ATAXIA	ATAXIA	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
family	family	NN	I-NP	O
members	member	NNS	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
somewhat	somewhat	RB	B-ADJP	O
ataxic	ataxic	JJ	I-ADJP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
onset	onset	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
ataxia	ataxia	NN	I-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
relation	relation	NN	B-NP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
current	current	JJ	I-NP	O
illness	illness	NN	I-NP	O
;	;	:	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
given	give	VBN	B-PP	O
the	the	DT	B-NP	O
fact	fact	NN	I-NP	O
that	that	IN	B-SBAR	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
fact	fact	NN	I-NP	O
that	that	IN	B-SBAR	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
sustained	sustain	VBN	I-VP	O
a	a	DT	B-NP	O
fall	fall	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
evening	evening	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
CT	CT	NN	I-NP	O
scan	scan	NN	I-NP	O
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
to	to	TO	I-VP	O
rule	rule	VB	I-VP	O
out	out	RP	B-PRT	O
a	a	DT	B-NP	O
subarachnoid	subarachnoid	JJ	I-NP	O
hemorrhage	hemorrhage	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
CT	CT	NN	I-NP	O
scan	scan	NN	I-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
hemorrhage	hemorrhage	NN	B-NP	O
and	and	CC	O	O
showed	show	VBD	B-VP	O
age-appropriate	age-appropriate	JJ	B-NP	O
atrophy	atrophy	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
Neurology	Neurology	NNP	I-NP	O
consult	consult	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
requested	request	VBN	I-VP	O
,	,	,	O	O
and	and	CC	O	O
recommendations	recommendation	NNS	B-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
CT	CT	NN	I-NP	O
scan	scan	NN	I-NP	O
,	,	,	O	O
as	as	RB	O	O
already	already	RB	B-VP	O
discussed	discuss	VBN	I-VP	O
,	,	,	O	O
were	be	VBD	B-VP	O
made	make	VBN	I-VP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
they	they	PRP	B-NP	O
recommended	recommend	VBD	B-VP	O
that	that	IN	B-SBAR	O
we	we	PRP	B-NP	O
check	check	VBP	B-VP	O
an	an	DT	B-NP	O
RPR	RPR	NN	I-NP	B-protein
,	,	,	O	O
B12	B12	NN	B-NP	B-protein
,	,	,	O	O
folate	folate	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
TSH	TSH	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
results	result	NNS	I-NP	O
are	be	VBP	B-VP	O
as	as	IN	B-SBAR	O
follows	follow	VBZ	B-VP	O
:	:	:	O	O
RPR	RPR	NN	B-NP	B-protein
was	be	VBD	B-VP	O
nonreactive	nonreactive	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
first	first	JJ	I-NP	O
draw	draw	NN	I-NP	O
of	of	IN	B-PP	O
B12	B12	NN	B-NP	B-protein
was	be	VBD	B-VP	O
233	233	CD	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
slightly	slightly	RB	B-ADJP	O
low	low	JJ	I-ADJP	O
normal	normal	JJ	B-ADJP	O
.	.	.	O	O

A	A	DT	B-NP	O
repeat	repeat	NN	I-NP	O
B12	B12	NN	I-NP	O
was	be	VBD	B-VP	O
564	564	CD	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
within	within	IN	B-PP	O
normal	normal	JJ	B-NP	O
limits	limit	NNS	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
folate	folate	NN	I-NP	O
was	be	VBD	B-VP	O
normal	normal	JJ	B-ADJP	O
at	at	IN	B-PP	O
4.9	4.9	CD	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
TSH	TSH	NN	I-NP	O
was	be	VBD	B-VP	O
slightly	slightly	RB	B-ADJP	O
low	low	JJ	I-ADJP	O
at	at	IN	B-PP	O
0.44	0.44	CD	B-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
Physical	Physical	JJ	I-NP	O
Therapy	Therapy	NN	I-NP	O
consult	consult	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
obtained	obtain	VBN	I-VP	O
to	to	TO	I-VP	O
assist	assist	VB	I-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
with	with	IN	B-PP	O
exercises	exercise	NNS	B-NP	O
to	to	TO	B-VP	O
improve	improve	VB	I-VP	O
his	his	PRP$	B-NP	O
strength	strength	NN	I-NP	O
.	.	.	O	O

By	By	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
ambulate	ambulate	VB	I-VP	O
without	without	IN	B-PP	O
difficulty	difficulty	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
having	have	VBG	I-VP	O
no	no	DT	B-NP	O
ataxia	ataxia	NN	I-NP	O
,	,	,	O	O
whatsoever	whatsoever	RB	B-ADVP	O
.	.	.	O	O

We	We	PRP	B-NP	O
feel	feel	VBP	B-VP	O
,	,	,	O	O
in	in	IN	B-PP	O
part	part	NN	B-NP	O
,	,	,	O	O
that	that	IN	B-SBAR	O
some	some	DT	B-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
ataxia	ataxia	NN	I-NP	O
may	may	MD	B-VP	O
have	have	VB	I-VP	O
been	be	VBN	I-VP	O
related	relate	VBN	I-VP	O
to	to	TO	B-PP	O
generalized	generalize	VBN	B-NP	O
weakness	weakness	NN	I-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
current	current	JJ	I-NP	O
illness	illness	NN	I-NP	O
.	.	.	O	O

PROBLEM	PROBLEM	NN	B-NP	B-protein
#	#	#	B-NP	I-protein
4	4	CD	I-NP	I-protein
:	:	:	O	O
DIABETES	DIABETES	NNS	B-NP	O
MELLITUS	MELLITUS	NNS	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
glucose	glucose	NN	I-NP	O
was	be	VBD	B-VP	O
194	194	CD	B-NP	O
.	.	.	O	O

Due	Due	JJ	B-PP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
oral	oral	JJ	I-NP	O
intake	intake	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
elected	elect	VBD	B-VP	O
to	to	TO	I-VP	O
hold	hold	VB	I-VP	O
his	his	PRP$	B-NP	O
Glyburide	Glyburide	NN	I-NP	O
and	and	CC	O	O
to	to	TO	B-VP	O
give	give	VB	I-VP	O
him	him	PRP	B-NP	O
insulin	insulin	NN	B-NP	O
subcu	subcu	NN	I-NP	O
.	.	.	O	O

on	on	IN	B-PP	O
a	a	DT	B-NP	O
sliding	slide	VBG	I-NP	O
scale	scale	NN	I-NP	O
basis	basis	NN	I-NP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
.	.	.	O	O

By	By	IN	B-PP	O
hospital	hospital	NN	B-NP	O
day	day	NN	I-NP	O
#	#	#	B-NP	O
4	4	CD	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
p.o.	p.o.	NN	I-NP	O
intake	intake	NN	I-NP	O
had	have	VBD	B-VP	O
improved	improve	VBN	I-VP	O
,	,	,	O	O
and	and	CC	O	O
we	we	PRP	B-NP	O
resumed	resume	VBD	B-VP	O
Glyburide	Glyburide	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
.	.	.	O	O

p.o.	p.o.	LS	B-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
with	with	IN	B-PP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
continued	continue	VBD	B-VP	O
Accucheks	Accuchek	NNS	B-NP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
b.i.d.	b.i.d.	JJ	I-NP	O
basis	basis	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
glucose	glucose	NN	I-NP	O
tended	tend	VBD	B-VP	O
to	to	TO	I-VP	O
run	run	VB	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
low	low	JJ	I-NP	O
200s	200s	CD	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
glucose	glucose	NN	I-NP	O
will	will	MD	B-VP	O
need	need	VB	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
perhaps	perhaps	RB	B-ADVP	O
one	one	PRP	B-NP	O
might	might	MD	B-VP	O
consider	consider	VB	I-VP	O
a	a	DT	B-NP	O
glucometer	glucometer	NN	I-NP	O
for	for	IN	B-PP	O
him	him	PRP	B-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
to	to	TO	B-VP	O
ensure	ensure	VB	I-VP	O
that	that	IN	B-SBAR	O
he	he	PRP	B-NP	O
has	have	VBZ	B-VP	O
good	good	JJ	B-NP	O
glucose	glucose	NN	I-NP	O
control	control	NN	I-NP	O
.	.	.	O	O

PROBLEM	PROBLEM	NN	B-NP	B-protein
#	#	#	B-NP	I-protein
5	5	CD	I-NP	I-protein
:	:	:	O	O
HEMATOLOGIC	HEMATOLOGIC	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
on	on	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
he	he	PRP	B-NP	O
takes	take	VBZ	B-VP	O
as	as	IN	B-SBAR	O
follows	follow	VBZ	B-VP	O
:	:	:	O	O
2.5	2.5	CD	B-NP	O
mg	mg	NN	I-NP	O
.	.	.	O	O

alternating	alternate	VBG	B-VP	O
with	with	IN	B-PP	O
3	3	CD	B-NP	O
mg	mg	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
was	be	VBD	B-VP	O
1.8	1.8	CD	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
was	be	VBD	B-VP	O
rechecked	rechecke	VBN	I-VP	O
on	on	IN	B-PP	O
6/2/95	6/2/95	CD	B-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
4.8	4.8	CD	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
Coumadin	Coumadin	NN	I-NP	O
was	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
couple	couple	NN	I-NP	O
of	of	IN	B-PP	O
days	day	NNS	B-NP	O
,	,	,	O	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
was	be	VBD	B-VP	O
rechecked	rechecke	VBN	I-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
;	;	:	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
2.4	2.4	CD	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
feel	feel	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
elevation	elevation	NN	I-NP	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
was	be	VBD	B-VP	O
probably	probably	RB	I-VP	O
related	relate	VBN	I-VP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	B-DNA
being	be	VBG	B-VP	O
on	on	IN	B-PP	O
antibiotics	antibiotic	NNS	B-NP	O
.	.	.	O	O

I	I	PRP	B-NP	O
have	have	VBP	B-VP	O
mentioned	mention	VBN	I-VP	O
this	this	DT	B-NP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
doctor	doctor	NN	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Reimer	Reimer	NNP	I-NP	O
He	He	NNP	I-NP	O
will	will	MD	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
clinic	clinic	JJ	I-NP	O
visit	visit	NN	I-NP	O
on	on	IN	B-PP	O
Monday	Monday	NNP	B-NP	O
,	,	,	O	O
7/22/95	7/22/95	CD	B-NP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
PENDING	PENDING	NN	I-NP	O
ON	ON	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
:	:	:	O	O
Legionella	Legionella	NN	B-NP	B-protein
antigen	antigen	NN	I-NP	I-protein
,	,	,	O	O
obtained	obtain	VBN	B-VP	O
on	on	IN	B-PP	O
10/2/95	10/2/95	CD	B-NP	O
.	.	.	O	O

Repeat	Repeat	NN	B-NP	O
stool	stool	NN	I-NP	O
for	for	IN	B-PP	O
Clostridium	Clostridium	NN	B-NP	O
difficile	difficile	JJ	I-NP	O
toxin	toxin	NN	I-NP	O
on	on	IN	B-PP	O
1/5/95	1/5/95	CD	B-NP	O
;	;	:	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
diarrhea	diarrhea	NN	I-NP	O
has	have	VBZ	B-VP	O
diminished	diminish	VBN	I-VP	O
,	,	,	O	O
and	and	CC	O	O
we	we	PRP	B-NP	O
do	do	VBP	B-VP	O
not	not	RB	I-VP	O
think	think	VB	I-VP	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
is	be	VBZ	B-VP	O
related	relate	VBN	I-VP	O
to	to	TO	B-PP	O
Clostridium	Clostridium	NNP	B-NP	O
difficile	difficile	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Atenolol	Atenolol	NN	B-NP	O
50	50	CD	B-NP	O
mg	mg	NN	I-NP	O
.	.	.	O	O

p.o.	p.o.	LS	B-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

Cardizem-SR	Cardizem-SR	JJ	B-NP	O
120	120	CD	I-NP	O
mg	mg	NN	I-NP	O
.	.	.	O	O

p.o.	p.o.	LS	B-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
Erythromycin	Erythromycin	NN	I-NP	O
500	500	CD	I-NP	O
mg	mg	NN	I-NP	O
.	.	.	O	O

p.o.	p.o.	LS	B-NP	O
q.i.d.	q.i.d.	NN	I-NP	O
x	x	SYM	B-NP	O
eight	eight	CD	B-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

Glyburide	Glyburide	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
.	.	.	O	O

p.o.	p.o.	LS	B-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

Lovastatin	Lovastatin	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
.	.	.	O	O

p.o.	p.o.	LS	B-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

Coumadin	Coumadin	NN	B-NP	O
2	2	CD	I-NP	O
mg	mg	NN	I-NP	O
.	.	.	O	O

p.o.	p.o.	LS	B-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

Nitroglycerin	Nitroglycerin	NN	B-NP	O
0.4	0.4	CD	I-NP	O
mg	mg	NN	I-NP	O
.	.	.	O	O

tablets	tablet	NNS	B-NP	O
sublingual	sublingual	JJ	I-NP	O
q.	q.	NN	I-NP	O
five	five	CD	B-NP	O
minutes	minute	NNS	I-NP	O
x	x	SYM	B-NP	O
three	three	CD	B-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
;	;	:	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
to	to	TO	B-VP	O
notify	notify	VB	I-VP	O
the	the	DT	B-NP	O
M.D.	M.D.	NNP	I-NP	O
if	if	IN	B-SBAR	O
the	the	DT	B-NP	O
pain	pain	NN	I-NP	O
fails	fail	VBZ	B-VP	O
to	to	TO	I-VP	O
resolve	resolve	VB	I-VP	O
after	after	IN	B-PP	O
three	three	CD	B-NP	O
tablets	tablet	NNS	I-NP	O
or	or	CC	O	O
if	if	IN	B-SBAR	O
he	he	PRP	B-NP	O
should	should	MD	B-VP	O
become	become	VB	I-VP	O
light-headed	light-headed	JJ	B-ADJP	O
while	while	IN	B-SBAR	O
taking	take	VBG	B-VP	O
those	those	DT	B-NP	O
tablets	tablet	NNS	I-NP	O
.	.	.	O	O

CONDITION	CONDITION	NN	B-NP	O
ON	ON	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
:	:	:	O	O
Good	Good	NNP	B-NP	O
.	.	.	O	O

DISPOSITION	DISPOSITION	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	B-PP	O
home	home	NN	B-NP	O
.	.	.	O	O

FOLLOW-UP	FOLLOW-UP	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Elvis	Elvis	NNP	I-NP	O
Alcantas	Alcantas	NNP	I-NP	O
in	in	IN	B-PP	O
clinic	clinic	NN	B-NP	O
on	on	IN	B-PP	O
Monday	Monday	NNP	B-NP	O
,	,	,	O	O
7/22/95	7/22/95	CD	B-NP	O
.	.	.	O	O

Dictated	Dictate	VBN	B-VP	O
By	By	IN	B-PP	O
:	:	:	O	O
CLAUDE	CLAUDE	NN	B-NP	O
TERRIAN	TERRIAN	NN	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
ROOSEVELT	ROOSEVELT	NNP	B-NP	O
J.	J.	NNP	I-NP	O
OAKESON	OAKESON	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
LB30	LB30	NNP	I-NP	O
BG005/4783	BG005/4783	NNP	I-NP	O
Batch	Batch	NNP	I-NP	O
:	:	:	O	O
0068	0068	CD	B-NP	O
Index	Index	NNP	I-NP	O
No	No	NNP	I-NP	O
.	.	.	O	O

NBOTLL4L5Z	NBOTLL4L5Z	NN	B-NP	O
D	D	NN	I-NP	O
:	:	:	O	O
5/10/95	5/10/95	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
11/14/95	11/14/95	CD	B-NP	O
CC	CC	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

VERN	VERN	NNP	B-NP	O
K.	K.	NNP	I-NP	O
IHNAT	IHNAT	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
LB30	LB30	.	O	B-DNA

